Motor network efficiency and disability in multiple sclerosis by Pardini, M. et al.
Matteo Pardini, MD
Özgür Yaldizli, MD
Varun Sethi, MD, PhD
Nils Muhlert, PhD
Zheng Liu, MD
Rebecca S. Samson, PhD
Daniel R. Altmann, PhD
Maria A. Ron, PhD,
FRCPsych
Claudia A.M. Wheeler-
Kingshott, PhD
David H. Miller, MD,
FMedSci
Declan T. Chard, PhD,
FRCP
Correspondence to
Dr. Pardini:
m.pardini@ucl.ac.uk
Editorial, page 1096
Supplemental data
at Neurology.org
Motor network efficiency and disability in
multiple sclerosis
ABSTRACT
Objective: To develop a composite MRI-based measure of motor network integrity, and determine if
it explains disability better than conventional MRI measures in patients with multiple sclerosis (MS).
Methods: Tract density imaging and constrained spherical deconvolution tractography were used
to identify motor network connections in 22 controls. Fractional anisotropy (FA), magnetization
transfer ratio (MTR), and normalized volume were computed in each tract in 71 people with
relapse onset MS. Principal component analysis was used to distill the FA, MTR, and tract volume
data into a single metric for each tract, which in turn was used to compute a composite measure of
motor network efficiency (composite NE) using graph theory. Associations were investigated
between the Expanded Disability Status Scale (EDSS) and the following MRI measures: compos-
ite motor NE, NE calculated using FA alone, FA averaged in the combined motor network tracts,
brain T2 lesion volume, brain parenchymal fraction, normal-appearing white matter MTR, and cer-
vical cord cross-sectional area.
Results: In univariable analysis, composite motor NE explained 58% of the variation in EDSS in
the whole MS group, more than twice that of the other MRI measures investigated. In a multivar-
iable regression model, only composite NE and disease duration were independently associated
with EDSS.
Conclusions: A composite MRI measure of motor NE was able to predict disability substantially
better than conventional non-network-based MRI measures. Neurology® 2015;85:1115–1122
GLOSSARY
AC-PC 5 anterior commissure–posterior commissure; BPF 5 brain parenchymal fraction; EDSS 5 Expanded Disability
Status Scale; FA 5 fractional anisotropy; GM 5 gray matter; GT 5 graph theory; MS 5 multiple sclerosis; MTI 5 magneti-
zation transfer imaging; MTR 5 magnetization transfer ratio; NAWM 5 normal-appearing white matter; NE 5 network effi-
ciency; PASAT 5 Paced Auditory Serial Addition Test; PCA 5 principal component analysis; PD 5 proton density; ROI 5
region of interest; RRMS 5 relapsing-remitting multiple sclerosis; SPMS 5 secondary progressive multiple sclerosis; TE 5
echo time; TOI 5 tract of interest; TR 5 repetition time; WM 5 white matter.
In multiple sclerosis (MS), the most widely used clinical score is the Expanded Disability Status
Scale (EDSS).1,2 However, while accepted as a primary outcome in treatment trials, its reliabil-
ity3 and sensitivity to change are limited, requiring large cohorts and lengthy follow-up to
reliably identify treatment effects. MRI measures, such as white matter (WM) lesion load,4
enable treatment effects to be detected in smaller cohorts but are not accepted primary outcomes
as their correlation with disability is modest.5,6 MRI measures are usually of the whole brain or
anatomical regions of interest (ROIs), potentially including functionally irrelevant, or over-
looking relevant, areas.7 An alternative is to evaluate networks underlying functions.8 A network
can be assessed as a single ROI, but information about connectivity is lost. In structural
connectomics studies, graph theory (GT)9,10 enables a single measure, such as network efficiency
(NE), to encapsulate network-wide damage while weighting the effects of pathology dependent
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on where it occurs. Such studies are usually
based on diffusion MRI measures,11 but in
MS, combining them with other measures,
such as magnetization transfer ratio (MTR),
could provide a more comprehensive assess-
ment of pathology.
The aims of this work were to determine
whether (1) motor network compared with
non-network-based MRI measures correlate
more closely with EDSS scores; (2) EDSS
scores correlate more with NE than WM frac-
tional anisotropy (FA) in the motor network;
and (3) EDSS scores correlate more with NE
computed using FA or FA and MTR.
METHODS Patients. Seventy-one patients with relapse-onset
MS (mean age 46.26 10.3 years; mean disease duration 15.46
10.0 years; 44 female, 27 male; 27 secondary progressive MS
[SPMS] and 44 relapsing-remitting MS [RRMS]) were
included in this study. Clinical and MRI assessments were not
undertaken in those who had had a relapse or received
corticosteroids within the preceding 4 weeks. The primary
clinical measure of this study was the EDSS.1 Clinical and
demographic data for the whole MS group and the SPMS and
RRMS subgroups are shown in table 1.
A group of 22 age- and sex-matched healthy controls (age
44.4 6 2.4 years; 13 female, 9 male), with no known neurologic
or psychiatric conditions, were also enrolled in the study.
Standard protocol approvals, registrations, and patient
consents. Written informed consent was obtained from all pa-
tients. This study was approved by the local institutional ethics
committee.
MRI protocol and analysis. An outline of the analysis pipeline
is shown in figure 1.
MRI protocol and preprocessing. Brain MRI was performed
on a Philips Achieva 3T system (Philips Healthcare, Best, Nether-
lands) using a 32-channel head coil. The high angular resolution
diffusion imaging scan consisted of a cardiac-gated spin-echo
echoplanar imaging sequence, with slices acquired in the axial-
oblique orientation aligned with the anterior commissure–
posterior commissure (AC-PC) line (2 3 2 3 2 mm3, 61
isotropically distributed diffusion-weighted directions with b 5
1,200 seconds/mm2, 7 b5 0 volumes, echo time [TE]5 68 ms,
repetition time [TR] 5 24 seconds [depending on the cardiac
rate], sensitivity encoding factor 5 3.1, field of view 112 3 112,
number of slices 72). In each subject we also acquired the
following: (1) dual-echo proton density (PD)/T2-weighted axial-
oblique scans aligned with the AC-PC line (13 13 3 mm3, TR5
3,500 ms, TE 5 19/85 ms, field of view 240 3 240), (2) 3D
sagittal T1-weighted fast field echo scan (1 3 1 3 1 mm3, TR 5
6.9 ms, TE 5 3.1 ms), and (3) magnetization transfer imaging
(MTI) scans (1 3 1 3 1 mm3, TR 5 6.4 ms, TE 5 2.7/4.3 ms,
field of view 256 3 256, number of slices 180).
Preprocessing steps included (1) removal of non-brain tissue
using FSL,12 (2) eddy-current correction of diffusion images and
vector realignment using FSL,12 and (3) fitting of the diffusion
tensor using Camino.13
Network-based analysis: Identification of the motor
network components and quantification of tract FA,
MTR, and volume. The pipeline for the identification of the
motor network components is reported in the e-Methods on
the Neurology® Web site at Neurology.org and summarized in
figure 1. Briefly, the cortical and subcortical gray matter (GM)
structures of the motor network were identified based on
published models of motor function14 using the Harvard-
Oxford cortical and subcortical structural atlas, included in
FSL.12 Using these as seed points, constrained spherical
Table 1 Demographic, MRI, and clinical data of patients withmultiple sclerosis and healthy controls enrolled in
the study
Whole MS group RRMS SPMS HC
Age, y 46.2 6 10.3 42.4 6 10.0 52.4 6 7.6 44.4 6 2.4
Sex, F/M 44/27 29/15 15/12 13/9
Disease duration, y 15.4 6 10.0 11.4 6 8.1 21.9 6 9.3 NA
Median EDSS (range) 4.5 (1–8.5) 2.0 (1–7) 6.5 (4–8.5) NA
Composite NE 0.57 6 0.05 0.59 6 0.04 0.54 6 0.04 0.66 6 0.03
FA NE 0.40 6 0.04 0.41 6 0.04 0.37 6 0.04 0.46 6 0.03
NAWM MTR, % 38.1 6 1.4 38.4 6 1.1 37.5 6 1.6 39.9 6 0.8
BPF 0.80 6 0.02 0.80 6 0.02 0.79 6 0.02 0.84 6 0.02
Whole network FA 0.45 6 0.06 0.47 6 0.06 0.43 6 0.06 0.49 6 0.04
WM PD/T2 LL vol, mL 8.50 6 10.28 7.60 6 10.92 9.97 6 9.13 NA
Cervical cord area, mm2 74.1 6 11.1 77.2 6 10.8 69.0 6 10.0 82.5 6 10.9
Abbreviations: BPF 5 brain parenchymal fraction; composite NE 5 multiparameter principal component–derived network
efficiency; EDSS 5 Expanded Disability Status Scale; FA 5 fractional anisotropy; FA NE 5 unimodal network efficiency
(based on fractional anisotropy values only); HC 5 healthy controls; MS5multiple sclerosis; MTR5magnetization transfer
ratio; NA 5 not applicable; NAWM 5 normal-appearing white matter; NE 5 network efficiency; RRMS 5 relapsing-remitting
multiple sclerosis; SPMS 5 secondary progressive multiple sclerosis; WM PD/T2 LL 5 white matter lesion load quantified
on proton density/T2 scans.
Values are mean 6 SD unless otherwise noted.
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deconvolution tractography15 was used to create in healthy
controls the population-weighted masks of all the WM tracts
connecting the motor network GM structures (i.e., masks for
all tracts of interest [TOIs]). FA, MTR, and normalized
volume were then computed for each TOI for all participants
with MS as described in the e-Methods.
Network-based analysis: Principal component analysis of
multiparameter MRI data. Principal component analysis
(PCA) is a data reduction technique that extracts the main compo-
nents that explain observed variation in multiple different measure-
ments. Practically, it can be used to distill multiple MRI measures
into fewer variables,16,17 so enabling multimodal MRI data to be
used where only unimodal data could otherwise be used. GT net-
work analysis works with single measurements for each WM tract,
and so in this work we used PCA to condense multimodal MRI
data from the WM tracts. To achieve this, FA, MTR, and normal-
ized volume data from all tracts in all patients were included in a
single PCA analysis. Each tract in each subject represented a sepa-
rate data point. The analysis revealed a single factor that explained
;80% of the variance in these 3 measures (in this order of associ-
ation), i.e., 80% of the unique information in the tracts’ FA, MTR,
and normalized volumemeasures. This value of this PCA factor was
then calculated in all tracts, rescaled between 0 and 1 across all
tracts, and then used in the subsequent GT network analysis.
Network-based analysis: Computation of multiparameter
and FA NE. NE, normalized to the maximum theoretical effi-
ciency of the network, was computed using the MATLAB Con-
nectivity Toolbox (www.brain-connectivity-toolbox.net). NE
was computed separately (1) based on the WM tract FA (as per
previous studies)11 to generate an FA-based NE measure (FA NE)
and (2) using the PCA main factor to generate a composite NE
measure incorporating effects of FA, MTR, and tissue volume. In
this analysis, higher NE values represent the potential for more
efficient information exchange.9,10
Other MRI metrics. All the tracts of the motor network were
merged to form a single mask of motor network WM. Mean
FA was then measured inside this mask (whole network FA).
Whole brain PD/T2-weighted lesion volumes, normal-
appearing WM (NAWM) MTR, brain parenchymal fraction
(BPF), and cervical cord area were measured. WM PD/T2
lesion load was measured using PD/T2 images and JIM
(Xinpase Systems; www.xinapse.com). NAWM MTR values
were computed from the WM mask (generated as above)
excluding PD/T2 WM lesions. BPF was computed using the
GM, WM, and CSF masks.18 Cervical spinal cord area was
measured using the T1-weighted volumetric images as
previously described.19
Statistical analysis. Log-transformed volume was used to nor-
malize the PD/T2 WM lesion load data. In the whole MS
group, associations between EDSS and MRI metrics were exam-
ined with Spearman and Pearson correlations. Multivariable as-
sociations with EDSS were examined using multiple linear
regression, with the MRI and demographic variables as predic-
tors. There was no evidence of residual non-normality, but as a
precaution the results assuming normality were confirmed using
a nonparametric bias-corrected and accelerated bootstrap with
1,000 replicates. There was evidence of heteroscedasticity,
but robust standard error20 regressions accommodating
heteroscedasticity did not materially alter results, therefore
standard least squares results are reported. Although the
regression p values, confidence intervals, and R2 are valid after
the residual checks above, regression coefficients must be
interpreted with caution: the EDSS scale does not have a
uniform linear interpretation. For this reason, the potentially
different association between EDSS and composite NE in
SPMS and RRMS was examined not with a conventional
interaction test, which compares slopes in the 2 groups, but
by comparing residual variance between the groups using an
F test, with smaller variance indicating better model fit. The
same analysis was performed dividing the whole MS group into
EDSS .3.5 or EDSS #3.5 subgroups. Statistical analyses were
performed in Stata 13.1 (Stata Corporation, College Station,
TX), and statistical significance reported at p , 0.05. Data are
reported as mean 6 SD, unless stated otherwise.
Figure 1 MRI analysis pipeline
CSD 5 constrained spherical deconvolution; FA 5 fractional anisotropy; GM 5 gray matter; HC 5 healthy controls; MNI 5 Montreal Neurologic Institute
(atlas); MTR 5 magnetization transfer ratio; MS 5 multiple sclerosis; NE 5 network efficiency; TDI 5 track density imaging.
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RESULTS MRI and EDSS associations in the whole MS
group. The connectivity matrix of the motor network
is shown in figure 2 (lower panel). The MRI mea-
surement values are given in table 1. Table 2 shows
pairwise correlations and R2 values among EDSS,
MRI, and demographic variables. While all correla-
tions were significant (table 2), composite NE had the
highest R2, explaining 58% of variance in EDSS
scores compared with 21% for FA NE (figure 3)
and with 18% for cervical cord area (the second
and third best performing metrics).
In a multivariable regression analysis including
composite NE and other MRI or demographic varia-
bles, disease duration was the only significant
predictor of EDSS independent from the composite
NE (model R2 0.64, composite NE p , 0.001, dis-
ease duration p 5 0.003). While none of the MRI
parameters were independent predictors of EDSS in
models with composite NE, the logarithmic transfor-
mation of T2 lesion load approached significance
(p 5 0.081), despite having the smallest univariable
R2 (0.09). However, log T2 lesion load lost signifi-
cance in a model with disease duration as a covariate.
MRI and EDSS association in RRMS and SPMS
subgroups. The composite NE was also significantly
associated with EDSS in the RRMS (R2 0.46) and
SPMS (R2 0.50) groups. The reduced R2 value
Figure 2 Gray and white matter components of the motor network
(A) Gray matter (GM) regions included in the motor network. (B) Connectivity matrix of the tracts included in the motor network based on the tractography
results. Included tracts are shown in light blue; tracts not identified by fiber tractography are shown in dark blue. As Sens C 5 associative parietal sensory
cortex; BA 5 Brodmann area; deep GM 5 deep gray matter; M2 5 secondary motor area; PFC 5 prefrontal cortex; S-M1 5 primary sensory motor cortex;
S2 5 secondary sensory area.
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observed in either subgroup compared to that in the
whole MS cohort is consistent with the smaller range
of values in the MRI and EDSS measures seen in the
subgroups when compared with the whole MS group.
A comparison of the residual variance in the 2 sub-
groups confirmed a higher variance in RRMS than in
SPMS (p, 0.001), providing evidence that compos-
ite NE prediction of EDSS is better in the SPMS than
in the RRMS group. Neither disease duration nor any
other variable predicted EDSS independently of com-
posite NE in separate models for SPMS and RRMS.
As reported in the supplementary data on the
Neurology® Web site at Neurology.org, the
association between composite NE and EDSS
remained significant when considering separately
patients with MS with EDSS #3.5 (27 patients) or
EDSS .3.5 (44 patients).
DISCUSSION The results of this study suggest that a
network-based multiparameter MRI measure
(composite NE) correlates significantly better with
EDSS scores than either conventional brain or
spinal cord MRI measures or NE calculated using
FA alone. Composite NE explained ;58% of the
variability in EDSS scores, with the next best
measure (FA NE) explaining about half of this
variability. No MRI variable predicted EDSS
independently of composite NE in the whole MS
group or in the SPMS and RRMS subgroups,
indicating that the network multiparameter MRI
approach used in this study improves the prediction
of clinical disability from MRI data.
Developing MRI markers of clinical outcomes has
proven difficult in MS. One major issue is the spatial
variability of MS pathology, which can have very
different effects on clinical outcomes dependent on
its location. As such, it is not surprising that the cor-
relations between whole brain MRI measures of MS
pathology and neurologic and cognitive disability5,6
are only modest, and ROI-based studies have not
clearly found a single region that consistently corre-
lates with motor outcomes.7 Network-based metrics
avoid these pitfalls by incorporating data from all the
functionally relevant components of a network.
Assessing performance across a neural network can
be undertaken in different ways, but in connectomics
GT has proven useful as it enables network-wide
characteristics to be summarized in a single metric.9,10
In MS, GT has been applied at a whole brain level
using functional MRI,21,22 diffusion,23,24 and volu-
metric MRI data,25 showing that MS pathology has
detectable effects on the function of networks. At a
single network level, we have previously found that
for Paced Auditory Serial Addition Test (PASAT)
scores, FA NE was better able to predict test perfor-
mance than the raw PASAT network WM tract FA
measures used to calculate NE.26 The results of the
present study confirm that this approach is applicable
to other brain networks in MS.
NE is calculated using a single measure only, and
previous structural GT studies have relied exclusively
on FA measures to calculate NE in MS23,24 and other
neurologic conditions.11 However, no single MRI
measure fully captures the spectrum of MS pathology,
and so using several different MRI measures may
provide a more comprehensive assessment. Previous
multiparameter MRI studies in MS, however, have
looked at each MRI measure independently.27,28 We
found that multiparameter MRI data combined using
PCA, when compared with FA alone, further
Table 2 Correlations and univariable R2 of the MRI measures with EDSS in the whole multiple sclerosis group
Demographic measures Spearman correlations Pearson correlations Univariable R2
Age rho 5 0.45, p , 0.001 r 5 0.49, p , 0.001 0.24
Disease duration rho 5 0.57, p , 0.001 r 5 0.55, p , 0.001 0.30
MRI measures
Composite NE rho 5 20.77, p , 0.001 r 5 20.77, p , 0.001 0.58
FA NE rho 5 20.52, p , 0.001 r 5 20.52, p , 0.001 0.28
NAWM MTR rho 5 20.37, p 5 0.002 r 5 20.34, p 5 0.004 0.12
BPF rho 5 20.30, p 5 0.011 r 5 20.31, p 5 0.009 0.10
Whole network FA rho 5 20.39, p , 0.001 r 5 20.43, p , 0.001 0.18
WM PD/T2 LL rho 5 0.27, p 5 0.026 r 5 0.08, p 5 0.486 (NS) 0.01 (NS)
log WM PD/T2 LL rho 5 0.27, p 5 0.026 r 5 0.30, p 5 0.012 0.09
Cervical cord area rho 5 20.41, p , 0.001 r 5 20.43, p , 0.001 0.18
Abbreviations: BPF 5 brain parenchymal fraction; composite NE 5 multiparameter principal component–derived network
efficiency; EDSS 5 Expanded Disability Status Scale; FA 5 fractional anisotropy; FA NE 5 unimodal network efficiency
(based on fractional anisotropy values only); MTR 5magnetization transfer ratio; NAWM 5 normal-appearing white matter;
WM PD/T2 LL 5 white matter lesion load quantified on proton density/T2 scans.
Neurology 85 September 29, 2015 1119
ª 2015 American Academy of Neurology. Unauthorized reproduction of this article is prohibited.
improved the association between network-based
MRI measures and EDSS scores, increasing the ex-
plained variance in EDSS scores from 21% using a
FA NE measure (based on FA alone) to 58% with a
composite NE that used MTR, FA, and normalized
tract volume measures. These 3 measures provide
complementary information on the underlying
pathology. MTR is reduced with demyelination,29
FA in WM tracts is reduced both with demyelination
and when axonal integrity is disrupted,30 and a
decrease in tissue volumes is thought to reflect axonal
loss and neurodegenerative changes.31 This may
account for the stronger correlation of the composite
NE measure with disability than NE computed using
FA alone. Associations between the composite NE
measure and EDSS were similar in RRMS (R2 0.46)
and SPMS (0.50), suggesting that this measure may
be equally useful across different disease subtypes.
A limitation of the study is the difficulty in iden-
tifying relevant GM areas to prime motor network
tractography. While we included all the main areas
described in published models of motor function,14
in people with MS, additional cortical areas are re-
cruited during the execution of motor tasks as disa-
bility increases.32 However, the majority of studies
localize these additional areas in contralateral motor
or prefrontal territories, i.e., all areas already included
in our network.32 In addition, our GM masks are
larger than those usually used in whole-brain connec-
tomics studies, potentially incorporating functionally
independent areas in some masks. This will tend to
reduce the apparent associations between network
measures and clinical scores. However, larger GM
regions, and consequently larger WM tract masks,
will reduce the impact of interindividual anatomical
variability. As this study sought to determine whether
a GT-based approach was worth pursuing in MS, we
focused on NE, the most commonly used GT metric.
As NE quantifies a physiologically relevant property,
i.e., the structural capacity for information transfer
between parts of a network, it was a suitable choice
for this proof-of-concept study. Other network prop-
erties that can be characterized using GT, such as
nodal degree (which represents the strength with
which a given GM region is connected to the rest
of the network),9,10 should be explored in future stud-
ies to determine which parameters best encapsulate
the effects of MS pathology on a network. Similarly,
the MRI parameters included in this study were based
on those most often used in MS clinical studies, but
again future work could determine whether or not
other parameters contribute further.
In this study, the generation of composite meas-
ures has been optimized for this dataset. While
including people with a wide range of EDSS scores
(1–8.5), a substantial proportion had EDSS scores
#3.5 (27 out of 71), and people who were in, or
had recently had, a relapse were not included. Further
studies in cohorts with a greater proportion of people
with higher EDSS scores, and in people during and
after relapses, are required to more fully assess the
performance of multiparameter motor network effi-
ciency measures throughout the EDSS scale, and to
determine whether or not associations between NE
and disability are disrupted by acute inflammatory
activity. This study used cross-sectional data from a
single center; however, treatment trials are often mul-
tisite and require serial measurements. Further work
is also needed to determine the reliability of motor
NE measures, and whether or not they need to be
tuned for MRI scanners individually in multicenter
studies. Finally, while the clinical outcome measure
used in this work was EDSS, future studies are war-
ranted to assess associations of MRI-based motor net-
work measures with more specific measures of upper
and lower limb function.
The results of this study suggest that multiparam-
eter MRI-based measures of motor network efficiency
may have a useful role in the assessment of clinically
relevant pathology. They were able to explain about
58% of the variation in EDSS scores in a diverse
group of people with MS, substantially and signifi-
cantly outperforming a series of conventional and
non-network-based MRI measures.
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Submissions must be 1,250 words or less with five or less references. A maximum of two figures or
two tables (or combination) can be incorporated if necessary. For complete submission require-
ments, please go to Neurology.org and click on “Information for Authors.” The submissions will
be reviewed by the editors and may be edited for clarity.
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